GL PharmTech

CompanySouth Korea

GL PharmTech develops one asset. Mostly small molecule; based in South Korea.

1
Asset
Furthest stage
Not known
0
Trials
1
Signal

Pipeline

1
  • Reco-Du

    Stage not known, Small molecule

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Signals1

Intelligence